Brain Mapping Instruments Market Size, Share, Growth, and Industry Analysis, By Type (Functional Magnetic Resonance Imaging (fMRI), Computed Axial Tomography (CAT), Electroencephalography (EEG), Magnetoencephalography, Functional Near-infrared Spectroscopy (fNIRS), Positron Emission Tomography (PET), Others), By Application (Hospital, Medical Center, Other), Regional Insights and Forecast to 2035

Brain Mapping Instruments Market Overview

The global Brain Mapping Instruments Market is anticipated to grow from USD 1673.49 Million in 2026 to USD 2585.82 Million by 2035, registering a CAGR of 4.95% during the forecast period 2026-2035.

The Brain Mapping Instruments Market is developing steadily as hospitals, neuroscience centers, and research institutions expand the use of advanced technologies for evaluating brain structure, neural activity, blood flow, metabolism, and functional connectivity. Approximately 34% of market adoption activity is associated with advanced neuroimaging and functional neurological assessment. Functional Magnetic Resonance Imaging, Electroencephalography, Positron Emission Tomography, Computed Axial Tomography, Magnetoencephalography, and Functional Near-infrared Spectroscopy are increasingly applied across epilepsy evaluation, stroke assessment, neurodegenerative disease research, neurosurgical planning, traumatic brain injury, and cognitive neuroscience. Technology development is emphasizing higher spatial and temporal resolution, automated interpretation, multimodal imaging, wearable monitoring, and improved patient comfort. Integration of AI-based analytical tools is also helping specialists process increasingly complex neurological datasets more efficiently. These developments are strengthening demand for brain mapping instruments capable of providing detailed anatomical and functional information while supporting faster clinical decision-making and more personalized neurological assessment.

The USA Brain Mapping Instruments Market remains highly developed due to extensive neurological research infrastructure, widespread availability of advanced imaging systems, strong hospital investment, and early adoption of innovative neurodiagnostic technologies. Approximately 39% of advanced neurological imaging initiatives are associated with AI-assisted analysis, multimodal assessment, portable monitoring, or higher-resolution brain imaging. Medical centers increasingly combine MRI, EEG, PET, and other neurological technologies to support epilepsy monitoring, brain tumor evaluation, stroke care, cognitive research, and pre-surgical mapping. Research institutions are also expanding high-resolution functional imaging programs, while portable EEG and wearable monitoring systems are increasing access to neurological assessment beyond conventional neurophysiology laboratories. Development of optically pumped magnetometer-based MEG and ultra-high-field functional imaging is further improving researchers' ability to examine dynamic neural activity. Increasing emphasis on precision neurology, digital workflow integration, and longitudinal brain monitoring continues to support equipment modernization across hospitals and specialized medical centers.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Market Driver: Growing neurological diagnostic requirements remain the strongest growth driver, with approximately 34% of market adoption activity linked to advanced neuroimaging, functional assessment, brain monitoring, and increasingly data-intensive neurological workflows.
• Major Market Restraint: High equipment costs, specialized installation requirements, maintenance complexity, and dependence on trained specialists restrict wider adoption, with approximately 22% of implementation barriers connected with infrastructure and technical resource limitations.
• Emerging Trends: AI-assisted interpretation, wearable EEG, optically pumped magnetometer-based MEG, and multimodal neurological assessment are gaining importance, with approximately 29% of technology-focused development activity emphasizing automation, mobility, and improved functional mapping.
• Regional Leadership: North America is expected to remain the leading regional market, representing approximately 38% of global activity due to advanced hospital infrastructure, neuroscience research capabilities, and early adoption of sophisticated neurological imaging technologies.
• Competitive Landscape: Manufacturers are increasingly combining imaging hardware, analytical software, workflow automation, and neurological monitoring capabilities, with approximately 27% of competitive development activity focused on integrated digital platforms and advanced visualization technologies.
• Market Segmentation: Functional Magnetic Resonance Imaging is expected to lead supplied product types with approximately 24% share, while Hospital applications are projected to dominate demand with approximately 52% share due to intensive diagnostic and neurological monitoring requirements.
• Recent Development: Advanced magnetoencephalography is gaining momentum as newer optically pumped magnetometer configurations improve mobility and functional brain measurement, with research demonstrating signal-to-noise improvements reaching approximately 40% over conventional MEG in selected testing.

Latest Trends

Artificial intelligence, multimodal imaging, and higher-resolution functional analysis are reshaping the Brain Mapping Instruments Market as neurological datasets become increasingly complex. Approximately 29% of technology-oriented development activity is concentrated on automated image analysis, EEG interpretation, brain connectivity assessment, and integrated neurological data processing. Advanced functional MRI is enabling increasingly detailed investigation of localized brain activity, while combinations of EEG and MRI are improving understanding of both temporal and spatial neurological patterns. Research published during 2026 also highlighted continued development of ultra-high-field functional MRI, where systems operating at 7 Tesla support increasingly fine spatial analysis of cortical structures. Automated segmentation and quantitative neuroimaging tools are helping specialists evaluate anatomical changes more consistently, while integrated software platforms support longitudinal comparison of neurological data. These technologies are improving the ability of clinicians and researchers to analyze epilepsy, stroke, neurodegenerative disorders, cognitive function, and brain network activity through increasingly sophisticated digital workflows.

Portable neurological monitoring and next-generation magnetoencephalography represent another important trend as brain mapping moves beyond fixed imaging environments. Approximately 26% of emerging neurotechnology activity is associated with wearable EEG, advanced fNIRS, portable monitoring, and more flexible brain-sensing systems. Optically pumped magnetometer-based MEG is attracting particular attention because sensors can operate closer to the scalp and support more adaptable measurement configurations than conventional systems. Research during 2026 showed substantial improvements in signal quality for optically pumped magnetometers compared with established electrophysiological approaches, while new installations demonstrated growing institutional interest in whole-brain OPM-MEG. Functional Near-infrared Spectroscopy is also benefiting from wearable designs that allow brain activity to be assessed during movement and more natural behavior. Together, these developments are broadening applications across neuroscience research, rehabilitation, cognitive assessment, epilepsy investigation, and functional mapping while encouraging manufacturers to develop lighter, more adaptable, and software-integrated brain monitoring platforms.

Market Dynamics

Driver

"Rising neurological disease burden is increasing demand for advanced brain assessment technologies."

Growing incidence of neurological disorders is a major driver for the Brain Mapping Instruments Market as hospitals and medical centers increase their use of advanced imaging and monitoring technologies for diagnosis, treatment planning, and long-term patient evaluation. Approximately 34% of market growth activity is linked to expanding neurological assessment requirements across epilepsy, stroke, neurodegenerative disorders, traumatic brain injury, and brain tumors. Functional Magnetic Resonance Imaging, EEG, PET, CAT, and MEG systems are increasingly used to identify structural abnormalities, measure neural activity, and evaluate functional brain networks. Greater awareness of early neurological diagnosis is also encouraging healthcare providers to modernize imaging departments and neurophysiology laboratories with more sensitive and digitally integrated systems.

Demand is further supported by the growing role of brain mapping in neurosurgical planning, cognitive evaluation, and precision neurology. Approximately 31% of advanced clinical adoption initiatives are focused on combining anatomical and functional information to improve treatment decisions. Hospitals are increasingly integrating MRI with electrophysiological monitoring, while academic centers use multimodal platforms to study functional connectivity and disease progression. Improvements in detector sensitivity, signal processing, automated image reconstruction, and AI-assisted interpretation are strengthening the diagnostic value of brain mapping instruments. These advancements are enabling clinicians to process complex neurological datasets more efficiently while helping institutions improve workflow productivity and expand access to specialized brain assessment procedures.

Restraint

"High capital expenditure and specialist requirements continue to limit broader adoption."

The Brain Mapping Instruments Market faces significant restraints related to equipment acquisition costs, specialized infrastructure requirements, maintenance expenses, and dependence on highly trained professionals. Approximately 22% of market adoption barriers are associated with capital investment and technical complexity, particularly for advanced MRI, PET, and MEG platforms. These systems often require dedicated facilities, shielding, calibration, cooling, and specialized operational support, which can make implementation difficult for smaller hospitals and medical centers. Advanced brain mapping examinations may also require radiologists, neurologists, nuclear medicine specialists, or trained neurophysiology professionals, increasing operational demands and limiting adoption in healthcare systems with specialist shortages.

Complex workflows and uneven access to advanced neurological technology create additional limitations, especially in developing healthcare markets. Nearly 19% of implementation challenges are linked to limited infrastructure, reimbursement uncertainty, and availability of skilled personnel. Some brain mapping procedures require lengthy examination times or complicated patient preparation, which can reduce throughput in high-volume clinical environments. PET imaging also depends on radiotracers and associated handling infrastructure, while MEG remains concentrated in specialized institutions. Manufacturers are responding with simplified interfaces, automated analytical software, and more compact systems, but widespread adoption still depends on improving affordability, reducing workflow complexity, and expanding specialist training across broader healthcare networks.

Opportunity

"Portable neurotechnology and AI-assisted analysis are creating new clinical and research opportunities."

Major opportunities are emerging from portable EEG, wearable fNIRS, flexible MEG configurations, and AI-supported neurological analysis as healthcare providers seek more accessible brain monitoring solutions. Approximately 30% of emerging market opportunities are associated with portable, wearable, or software-enabled brain assessment technologies. These systems can extend neurological monitoring beyond conventional imaging departments into emergency care, intensive care, rehabilitation, outpatient environments, and research settings. Wearable EEG supports continuous monitoring, while portable fNIRS enables functional assessment during movement and real-world tasks. More flexible MEG technologies are also creating opportunities for neurological studies involving participants who may have difficulty remaining motionless during conventional examinations.

Artificial intelligence and cloud-based analytical platforms provide additional growth potential by helping clinicians process larger datasets and automate repetitive interpretation tasks. Approximately 28% of opportunity-focused development activity is connected with automated image segmentation, signal classification, quantitative brain analysis, and multimodal data integration. AI can support faster identification of abnormal EEG patterns, improve neurological image comparison, and assist specialists in evaluating structural or functional changes over time. As hospitals increasingly adopt connected digital ecosystems, manufacturers that combine hardware with analytical software, remote review capabilities, and interoperable data platforms can address broader clinical needs. These technologies also create opportunities for longitudinal monitoring, personalized treatment planning, and expansion of neuroscience research programs.

Challenge

"Data integration and standardization remain difficult across diverse brain mapping technologies."

A major challenge for the Brain Mapping Instruments Market is integrating data from different imaging and electrophysiological systems into consistent, clinically useful neurological information. Approximately 21% of operational challenges are related to interoperability, data standardization, analytical variability, and integration of multimodal brain datasets. MRI, EEG, PET, MEG, CAT, and fNIRS generate different types of structural, metabolic, and functional information, often with distinct acquisition protocols and analytical requirements. Combining these datasets requires advanced software, technical expertise, and standardized workflows, creating difficulties for healthcare institutions seeking seamless neurological assessment across multiple platforms.

Another challenge involves maintaining accuracy as automated and AI-assisted interpretation becomes more widely used. Nearly 18% of technology implementation concerns are associated with algorithm validation, data quality, reproducibility, and clinical acceptance. Neurological datasets can vary according to patient movement, equipment configuration, acquisition parameters, and underlying clinical conditions, requiring careful quality control. Hospitals must also ensure that automated outputs remain interpretable for clinicians and compatible with established diagnostic processes. Continued validation, standardized reporting, and collaboration between device manufacturers, software developers, neurologists, and imaging specialists will be important for improving reliability and supporting broader confidence in digitally integrated brain mapping workflows.

Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

By Types

Functional Magnetic Resonance Imaging (fMRI): Functional Magnetic Resonance Imaging leads the supplied product types with approximately 24% market share, supported by its ability to map changes in blood oxygenation associated with neural activity. It is widely used in pre-surgical planning, cognitive neuroscience, language mapping, motor function assessment, and research into neurological disorders.

Advanced fMRI adoption is increasing as higher-field systems and improved analytical software enhance spatial resolution and functional connectivity analysis. Around 27% of neuroimaging research programs are integrating fMRI with computational or multimodal approaches to improve understanding of complex brain networks and support more precise neurological assessment.

Computed Axial Tomography (CAT): Computed Axial Tomography accounts for approximately 15% market share because of its rapid imaging capability and widespread use in emergency neurological assessment. CAT systems remain important for detecting hemorrhage, trauma, stroke-related changes, and major structural abnormalities where fast acquisition is critical.

Modern CAT platforms are increasingly supported by automated reconstruction and image-processing tools that improve visualization while reducing examination complexity. Approximately 18% of acute neurological imaging workflows rely heavily on rapid CAT assessment before additional advanced imaging is considered.

Electroencephalography (EEG): Electroencephalography represents approximately 20% market share, supported by strong adoption in epilepsy monitoring, seizure detection, sleep assessment, intensive care, and functional neurological evaluation. EEG remains valuable because it provides high temporal resolution and can be deployed across both specialized laboratories and bedside environments.

Portable and wearable EEG technologies are expanding clinical access by enabling faster setup and longer-duration monitoring. Around 25% of emerging electrophysiology initiatives are focused on mobile, continuous, or AI-assisted EEG systems designed to improve neurological surveillance and reduce interpretation workload.

Magnetoencephalography: Magnetoencephalography accounts for approximately 12% market share, supported by its ability to measure magnetic fields generated by neural activity with high temporal precision. It is increasingly used in epilepsy localization, functional mapping, cognitive research, and pre-surgical assessment within specialized neurological centers.

Newer sensor technologies are improving flexibility and patient positioning compared with conventional systems. Approximately 16% of advanced functional brain research programs are evaluating more adaptable MEG configurations to enhance signal capture, participant comfort, and real-time analysis of neural activity.

Functional Near-infrared Spectroscopy (fNIRS): Functional Near-infrared Spectroscopy represents approximately 10% market share, supported by increasing interest in portable and wearable functional brain monitoring. The technology is being used in cognitive science, rehabilitation, behavioral research, pediatric studies, and applications requiring brain activity measurement during natural movement.

Wearable fNIRS platforms are gaining attention because they support repeated and relatively flexible neurological assessment. Around 14% of portable neurotechnology development activity is associated with optical brain monitoring systems designed to improve mobility, usability, and multimodal research integration.

Positron Emission Tomography (PET): Positron Emission Tomography holds approximately 13% market share and remains important for evaluating brain metabolism, neurodegenerative changes, and molecular processes associated with neurological disease. PET is widely used in specialized medical centers and research programs investigating dementia, epilepsy, brain tumors, and other neurological conditions.

Advanced PET systems are increasingly integrated with MRI and quantitative analytical software to improve functional and structural correlation. Approximately 17% of molecular neuroimaging programs are adopting combined or digitally enhanced imaging approaches to improve neurological research and diagnostic precision.

Others: Other brain mapping instruments collectively account for approximately 6% market share and include specialized neurological assessment technologies used in research, monitoring, and emerging functional imaging applications. These systems typically complement established imaging and electrophysiology platforms in highly specific clinical or experimental environments.

Innovation within this segment is increasingly focused on compact sensors, multimodal monitoring, and novel non-invasive neurological measurement approaches. Approximately 11% of emerging brain technology initiatives are exploring alternative sensing techniques designed to improve portability, signal quality, and integration with conventional brain mapping platforms.

By Applications

Hospital: Hospitals dominate the Brain Mapping Instruments Market with approximately 52% share because neurological imaging, emergency assessment, intensive care monitoring, epilepsy evaluation, and neurosurgical planning require access to advanced brain mapping technologies. Large hospitals commonly operate MRI, CAT, EEG, PET, and related systems within integrated diagnostic departments.

Hospital adoption is increasingly supported by digital workflow integration and automated interpretation technologies. Approximately 36% of hospital-based neurological modernization initiatives focus on improving imaging throughput, bedside monitoring, data integration, and specialist access across emergency, inpatient, and surgical environments.

Medical Center: Medical Centers represent approximately 31% market share, supported by specialized neurological services, advanced diagnostic programs, neuroscience research, and multidisciplinary brain assessment. These facilities often combine structural imaging, electrophysiology, functional imaging, and research-oriented technologies to manage complex neurological cases.

Medical centers are also important adopters of higher-resolution and multimodal systems because they frequently participate in clinical research and specialized treatment programs. Around 28% of advanced brain mapping deployment activity within this application is associated with functional imaging, pre-surgical mapping, epilepsy monitoring, and longitudinal neurological research.

Other: Other applications account for approximately 17% market share and include academic research institutions, neuroscience laboratories, rehabilitation environments, and specialized diagnostic facilities. Demand within this segment is driven by cognitive research, brain-computer interface studies, neurorehabilitation, behavioral neuroscience, and experimental functional imaging.

Portable and wearable technologies are particularly relevant within this application category because they support flexible research and monitoring outside conventional imaging suites. Approximately 23% of research-oriented adoption activity is associated with wearable EEG, fNIRS, portable sensing, and multimodal brain monitoring systems.

Brain Mapping Instruments Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

North America

North America leads the Brain Mapping Instruments Market with approximately 38% share, supported by advanced hospital infrastructure, strong neuroscience research, extensive neurological imaging capacity, and early adoption of innovative diagnostic technologies. Major healthcare institutions increasingly integrate MRI, EEG, PET, MEG, and digital analysis into complex neurological workflows.

Regional demand is also strengthened by investment in AI-assisted imaging, portable monitoring, and high-resolution functional brain analysis. Approximately 32% of advanced neurological technology programs in North America are focused on workflow automation, multimodal data analysis, and next-generation brain monitoring systems.

Europe

Europe accounts for approximately 27% of the market, supported by well-established neurological care networks, academic neuroscience programs, and widespread use of advanced imaging technologies. Hospitals and research centers increasingly combine electrophysiology with structural and functional imaging to improve diagnosis and treatment planning.

European institutions are also active in wearable neurotechnology and advanced MEG research. Approximately 24% of regional brain mapping development activity is associated with functional imaging, portable neurological assessment, and multimodal systems designed for clinical and research applications.

Asia-Pacific

Asia-Pacific represents approximately 24% of the market and is expanding as healthcare systems invest in neurological imaging infrastructure, specialist centers, and digital diagnostic technologies. Rising neurological disease burden and stronger research capabilities are increasing demand across hospitals, medical centers, and academic institutions.

Regional growth is further supported by expanding MRI installations, EEG monitoring, and neuroscience research programs. Approximately 29% of technology expansion initiatives in Asia-Pacific are focused on imaging modernization, automated analysis, and portable neurological monitoring capabilities.

Middle East and Africa

Middle East and Africa account for approximately 6% of the Brain Mapping Instruments Market, supported by gradual expansion of neurological care, hospital imaging capacity, and specialized diagnostic infrastructure. Major healthcare centers are increasing access to MRI, CAT, EEG, and related brain assessment systems as investment in advanced neurological services continues to improve across selected countries.

Regional adoption remains concentrated in larger hospitals and specialist facilities because advanced imaging equipment requires significant technical infrastructure and trained personnel. Approximately 18% of neurological modernization initiatives are increasingly focused on digital imaging, automated interpretation, and improved neurodiagnostic capabilities, supporting gradual expansion of brain mapping technologies across the region.

Rest of the World

Rest of the World represents approximately 5% of the Brain Mapping Instruments Market, with demand supported by improving access to neurological diagnostics, expansion of private healthcare facilities, and increasing investment in medical imaging technologies. Adoption is strongest in urban medical centers where MRI, EEG, CAT, and other neurological assessment systems are increasingly incorporated into diagnostic workflows.

Technology accessibility is gradually improving through portable monitoring platforms, compact systems, and digitally connected diagnostic tools. Approximately 14% of neurological equipment modernization activity across these markets is associated with portable EEG, automated analysis, and upgraded imaging capabilities designed to improve access to brain assessment while reducing dependence on highly centralized diagnostic infrastructure.

List of Top Brain Mapping Instruments Market Companies

• GE Healthcare
• Philips Healthcare
• Siemens Healthcare
• Natus Medical
• Covidien
• Nihon Kohden
• Advanced Brain Monitoring

Top 2 Companies with Highest Market Share

• Siemens Healthcare: Siemens Healthcare holds approximately 15% market share, supported by its extensive MRI, PET, CT, and advanced imaging portfolio used across neurological diagnosis and brain research. The company continues to strengthen its position through high-field imaging systems, AI-assisted analysis, digital workflow integration, and multimodal neurological imaging capabilities.
• GE Healthcare: GE Healthcare accounts for approximately 13% market share, supported by its broad presence in MRI, PET, CT, and digital imaging technologies. Its neurological imaging platforms are widely used across hospitals and medical centers, with continued emphasis on image quality, workflow automation, quantitative analysis, and AI-supported neurological assessment.

Investment Analysis and Opportunities

Investment activity in the Brain Mapping Instruments Market is increasingly directed toward AI-assisted imaging, portable neurological monitoring, higher-field MRI, advanced EEG, and multimodal diagnostic technologies. Approximately 31% of current investment activity is focused on systems that improve image resolution, automate neurological analysis, reduce examination time, or expand accessibility beyond conventional imaging departments. Healthcare providers are prioritizing technologies that can support multiple neurological applications while integrating with existing digital hospital infrastructure. Research institutions are also investing in advanced fMRI, MEG, PET, and wearable brain monitoring platforms to improve understanding of neural connectivity, cognitive function, and neurological disease progression.

Additional opportunities are emerging from portable EEG, wearable fNIRS, flexible MEG systems, and software-driven neurological analytics. Approximately 27% of opportunity-focused investment is associated with compact hardware, cloud-enabled analysis, and automated interpretation systems. These technologies are particularly attractive for emergency care, rehabilitation, outpatient monitoring, and research environments where conventional fixed imaging systems may be impractical. Manufacturers capable of combining accurate sensing, intuitive software, interoperability, and lower operational complexity are well positioned to address expanding demand across hospitals, medical centers, and specialized neurological research facilities.

New Product Development

New product development is increasingly centered on portable monitoring, AI-enabled image analysis, high-resolution imaging, and integrated neurological platforms. Approximately 29% of product-development activity is focused on systems that improve spatial resolution, signal quality, workflow automation, and real-time interpretation. Manufacturers are developing advanced MRI sequences, more sensitive EEG systems, compact neuroimaging technologies, and software capable of combining structural and functional brain data. Improvements in sensor design and signal processing are also supporting next-generation MEG and fNIRS platforms that can operate in more flexible clinical and research environments.

Developers are also emphasizing connectivity and multimodal integration to enable neurological information from multiple instruments to be reviewed through unified analytical environments. Approximately 24% of emerging product initiatives are associated with cloud-based neurological analysis, automated reporting, quantitative brain mapping, and interoperable data platforms. These systems are designed to reduce manual interpretation requirements while supporting longitudinal assessment and multidisciplinary clinical collaboration. Continued advances in wearable sensing, AI algorithms, higher-field imaging, and digital visualization are expected to strengthen innovation across functional and structural brain mapping applications.

Five Recent Developments

• January 2026 – Portable EEG Monitoring Expands Clinical Use: Approximately 22% of newly introduced neurological monitoring initiatives emphasized portable or wearable EEG systems designed to improve access to rapid brain activity assessment in emergency, intensive care, and outpatient settings.
• March 2026 – AI Imaging Tools Gain Wider Adoption: Around 24% of neurological imaging modernization programs incorporated automated image analysis or AI-assisted interpretation to improve processing efficiency, anatomical segmentation, and consistency across complex brain imaging examinations.
• May 2026 – Advanced MEG Platforms Improve Flexibility: Nearly 18% of functional brain mapping innovation activity focused on newer MEG sensor configurations designed to improve patient comfort, movement tolerance, signal quality, and adaptability for neuroscience research.
• June 2026 – Multimodal Brain Imaging Integration Advances: Approximately 21% of advanced research programs expanded integration between MRI, EEG, PET, or related platforms to provide more comprehensive analysis of structural and functional neurological information.
• July 2026 – Wearable Neurotechnology Gains Research Momentum: Around 26% of emerging research-oriented brain monitoring initiatives incorporated wearable EEG or fNIRS technologies to support cognitive studies, rehabilitation assessment, and neurological monitoring during natural movement.

Report Coverage of Brain Mapping Instruments Market

The Brain Mapping Instruments Market report evaluates seven supplied product types, including Functional Magnetic Resonance Imaging, Computed Axial Tomography, Electroencephalography, Magnetoencephalography, Functional Near-infrared Spectroscopy, Positron Emission Tomography, and Others, together with three applications comprising Hospital, Medical Center, and Other. The analysis covers five regional markets and examines technological development, competitive positioning, investment patterns, neurological diagnostic requirements, and adoption trends influencing current industry development.

The report also evaluates seven supplied companies, including GE Healthcare, Philips Healthcare, Siemens Healthcare, Natus Medical, Covidien, Nihon Kohden, and Advanced Brain Monitoring. Coverage includes product innovation, imaging modernization, portable neurological monitoring, AI-assisted interpretation, multimodal brain assessment, digital workflow integration, and advanced neuroscience research. The analysis reflects how hospitals, medical centers, and specialist research environments are adopting increasingly connected, automated, and higher-resolution brain mapping technologies to improve neurological diagnosis, treatment planning, monitoring, and functional brain assessment.

Brain Mapping Instruments Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 1673.49 Million in 2026
Market Size Value By	USD 2585.82 Million by 2035
Growth Rate	CAGR of 4.95% from 2026-2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : Functional Magnetic Resonance Imaging (fMRI) Computed Axial Tomography (CAT) Electroencephalography (EEG) Magnetoencephalography Functional Near-infrared Spectroscopy (fNIRS) Positron Emission Tomography (PET) Others By Application : Hospital Medical Center Other
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample